BDBM419260 5-tert-Butyl-7-(3,3-difluoropyrrolidin-1-yl)-3-({2-[3-(trifluoromethyl)-3H-diaziren-3-yl]phenyl}methyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidine::US10457684, Example 4

SMILES CC(C)(C)c1nc(N2CCC(F)(F)C2)c2nnn(Cc3ccccc3C3(N=N3)C(F)(F)F)c2n1

InChI Key InChIKey=ODDDGKBVDWLLML-UHFFFAOYSA-N

Data  2 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 419260   

TargetCannabinoid receptor 2(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM419260(5-tert-Butyl-7-(3,3-difluoropyrrolidin-1-yl)-3-({2...)
Affinity DataKi:  4.20nMAssay Description:The affinity of the compounds of the invention for cannabinoid receptors was determined using recommended amounts of membrane preparations (PerkinElm...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCannabinoid receptor 1(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM419260(5-tert-Butyl-7-(3,3-difluoropyrrolidin-1-yl)-3-({2...)
Affinity DataKi:  488nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent